Document is current
Any future updates will be listed below
-
Authors
Wu, Yilan
Qian, Bo
Li, Tingyao https://orcid.org/0000-0003-3844-0522
Qin, Yiming
Guan, Zhouyu https://orcid.org/0009-0008-5102-0067
Chen, Tingli
Jia, Yali https://orcid.org/0000-0002-2784-1905
Zhang, Ping https://orcid.org/0000-0002-4601-0779
Zeng, Dian https://orcid.org/0000-0002-5592-9584
Moroi, Sayoko
Raman, Rajiv
Thinggaard, Benjamin Sommer https://orcid.org/0000-0002-3450-3568
Pedersen, Frederik
Ñehe, José Alogo Obiang
Kamalden, Tengku Ain
Zhou, Yukun https://orcid.org/0000-0002-0840-6422
Jin, Yixiao
Li, Huating https://orcid.org/0000-0003-0526-5545
Ran, An Ran https://orcid.org/0000-0003-4592-4867
Yang, Dawei
Meng, Ziyao
Peng, Qingsheng
Zheng, Ying Feng https://orcid.org/0000-0002-0914-7864
Wang, Dingqiao https://orcid.org/0009-0007-2648-6677
Ji, Hongwei https://orcid.org/0000-0003-3657-4666
Zang, Pengxiao
Yin, Changchang
Shen, Jie
Chen, Youxin https://orcid.org/0000-0002-7231-5058
Yu, Weihong
Dai, Rongping
Zhang, Chenxi
Zhao, Xinyu
Wang, Xiangning https://orcid.org/0000-0003-2608-9026
Chen, Yan
Wu, Qiang
Xie, Hongbin
Szeto, Simon K. H. https://orcid.org/0000-0001-9377-7377
Chan, Julia Y. Y. https://orcid.org/0000-0003-2504-9532
Chan, Victor T. T.
Xie, Hua-Tao https://orcid.org/0000-0003-4027-691X
Wei, Ruili
Li, Jin
Ma, Weizhi https://orcid.org/0000-0001-5604-7527
Zhu, Lei
Wang, Hongqiu
Fu, Huazhu https://orcid.org/0000-0002-9702-5524
Wang, Wenxiao https://orcid.org/0000-0001-7328-0267
Lin, Shan
Xu, Zejun
Guan, Nian
Zhang, Xiao
Grzybowski, Andrzej https://orcid.org/0000-0002-3724-2391
Gołębiowska-Bogaj, Monika
Gawęcki, Maciej
Smedowski, Adrian
Szaraniec, Wojciech
Wu, You https://orcid.org/0000-0001-9672-6129
Wen, Yang
Chen, Xiang
Yao, Yuanqi
,
Evans, Joshua
Letson, Alan
Davidorf, Frederik
Adeli, Mona
Chen, Peter
Mendel, Thomas A.
Huang, Yi
Bian, Xiyun
Wang, Jing
Yang, Xiaolong
Zhang, Haifang
Li, Yihan
Qu, Bo
Yuan, Hongzhi
Guo, Mengxiang
Wang, Dingqiao
Zhou, Ming
Shi, Wen
Lin, Shiqun
Zhou, Yan
Skollerud, Lars Morten
Thinggaard, Benjamin Sommer
Pedersen, Frederik
Smith, Bjarke Steenberg
Taha, Andreas Abou
Ñehe, José Alogo Obiang
Mikue, Celestino Edjang Nguema
Venkatakrishnan, Praveena
Shah, Dhaivat
Tripathi, Abhishek Kumar
Bhatt, Dharshan
Kala, Urvashi
Karra, Abhishek
Kamalden, Tengku Ain
Iqbal, Tajunisah
Wah, Penny Lott Pooi
Ahmad, Marium Jamaluddin
Amir, Nurul Najieha
Effendi-Tenang, Irina
Lim, Lee-Ling https://orcid.org/0000-0002-6214-6924
Cheung, Carol Y. https://orcid.org/0000-0002-9672-1819
Tan, Gavin Siew Wei https://orcid.org/0000-0001-5383-7136
Grauslund, Jakob
Ruamviboonsuk, Paisan
Sivaprasad, Sobha
Keane, Pearse A. https://orcid.org/0000-0002-9239-745X
Wang, Ya Xing https://orcid.org/0000-0003-2749-7793
Tham, Yih-Chung https://orcid.org/0000-0002-6752-797X
Cheng, Ching-Yu https://orcid.org/0000-0003-0655-885X
Wong, Tien Yin https://orcid.org/0000-0002-8448-1264
Sheng, Bin https://orcid.org/0000-0001-8510-2556
- License Information
-
More Information
Article History
Received: 24 October 2024
Accepted: 16 July 2025
First Online: 28 August 2025
Competing interests
: Y.J. is a patent holder of Optovue/Visionix, Inc., Optos plc and Genentech, Inc. She receives financial support from Genentech, Inc., and she receives financial compensation from Optovue/Visionix, Inc. and Genentech, Inc. P.A.K. is a co-founder of Cascader Ltd., has acted as a consultant for Retina Consultants of America, Roche, Boehringer Ingleheim and Bitfount and is an equity owner in Big Picture Medical. He has received speaker fees from Zeiss, Thea, Apellis and Roche. He has received travel support from Bayer and Roche. He has attended advisory boards for Topcon, Bayer, Boehringer Ingleheim and Roche. T.Y.W. is a consultant for AbbVie Pte Ltd., Aldropika Therapeutics, Bayer, Boehringer Ingelheim, Zeiss, Genentech, Iveric Bio, Novartis, Opthea Limited, Plano, Quaerite Biopharm Research Ltd., Roche, Sanofi and Shanghai Henlius. He is an inventor, holds patents and is a co-founder of start-up companies EyRiS and Visre, which have interests in, and develop digital solutions for, eye diseases. All potential conflicts of interests for consultancy, advisory boards and positions in the start-up companies and financial renumeration, if any, are managed by institutional policies under SingHealth and Tsinghua University. The other authors declare no competing interests.
